Shenghui He

4PUBLICATIONS
20CO-AUTHORS
Gene and molecular therapyEpigenetics (incl. genome methylation and epigenomics)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 17, 2021
ZMYND11-MBTD1 induces leukemogenesis through hijacking NuA4/TIP60 acetyltransferase complex and a PWWP-mediated chromatin association mechanism.

Jie Li, Phillip M Galbo, Weida Gong

|Nov 03, 2020
BAHCC1 binds H3K27me3 via a conserved BAH module to mediate gene silencing and oncogenesis.

Huitao Fan, Jiuwei Lu, Yiran Guo

|Aug 27, 2020
The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer.

Shenghui He

|Apr 28, 2017
Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustion.

Shenghui He, Patrick J Roberts, Jessica A Sorrentino

Pageof 1

Frequent Collaborators

2 joint publications

Gang Greg Wang

2 joint publications

Weida Gong

2 joint publications

Yiran Guo

2 joint publications

Yi-Hsuan Tsai